110 related articles for article (PubMed ID: 35325682)
1. Efficacy of Brahmi vati in generalised anxiety disorder - Randomized double blind comparative clinical trial.
Khot SG; Tubaki BR; Gonugade VB
J Ayurveda Integr Med; 2022; 13(2):100552. PubMed ID: 35325682
[TBL] [Abstract][Full Text] [Related]
2. Effect of Brahmi vati and Sarpagandha Ghana vati in management of essential hypertension - A randomized, double blind, clinical study.
Mishra D; Tubaki BR
J Ayurveda Integr Med; 2019; 10(4):269-276. PubMed ID: 29242090
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of Manasamitra Vataka (an Ayurveda medication) on generalized anxiety disorder with comorbid generalized social phobia: a randomized controlled study.
Tubaki BR; Chandrashekar CR; Sudhakar D; Prabha TN; Lavekar GS; Kutty BM
J Altern Complement Med; 2012 Jun; 18(6):612-21. PubMed ID: 22784349
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of Ayurveda based assessment scale for anxiety.
Tubaki BR; Lavekar GS; Chandrashekar CR; Sathyaprabha TN; Kutty BM
J Ayurveda Integr Med; 2023; 14(6):100765. PubMed ID: 37913740
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of Shu-gan-qing-re formula for generalized anxiety disorder: study protocol for a multi-center, prospective, double-blind, double-dummy, randomized controlled trial.
Chen P; Zhu H; Ning Y; Yin D; Jia H
Trials; 2020 Mar; 21(1):266. PubMed ID: 32171323
[TBL] [Abstract][Full Text] [Related]
6. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
Griebel G; Beeské S; Stahl SM
J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
[TBL] [Abstract][Full Text] [Related]
7. The comparative clinical study of efficacy of Gamisoyo-San (Jiaweixiaoyaosan) on generalized anxiety disorder according to differently manufactured preparations: multicenter, randomized, double blind, placebo controlled trial.
Park DM; Kim SH; Park YC; Kang WC; Lee SR; Jung IC
J Ethnopharmacol; 2014 Dec; 158 Pt A():11-7. PubMed ID: 25456420
[TBL] [Abstract][Full Text] [Related]
8. Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials.
Katz IR; Reynolds CF; Alexopoulos GS; Hackett D
J Am Geriatr Soc; 2002 Jan; 50(1):18-25. PubMed ID: 12028242
[TBL] [Abstract][Full Text] [Related]
9. Standardization of a traditional polyherbo-mineral formulation - Brahmi vati.
Mishra A; Mishra AK; Ghosh AK; Jha S
Afr J Tradit Complement Altern Med; 2013; 10(3):390-6. PubMed ID: 24146464
[TBL] [Abstract][Full Text] [Related]
10. Effects of Mamsyadi Kwatha in primary insomnia - A randomized controlled trial.
Lad A; R Tubaki B; S KS
J Ayurveda Integr Med; 2023; 14(6):100830. PubMed ID: 38035532
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
Carter NJ; McCormack PL
CNS Drugs; 2009; 23(6):523-41. PubMed ID: 19480470
[TBL] [Abstract][Full Text] [Related]
13. Putative Antidepressant Effect of Chamomile (
Amsterdam JD; Li QS; Xie SX; Mao JJ
J Altern Complement Med; 2020 Sep; 26(9):813-819. PubMed ID: 31808709
[No Abstract] [Full Text] [Related]
14. An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD).
Cutler NR; Sramek JJ; Macpherson AE; Doss MG; Benes CO; Howard SF
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):685-94. PubMed ID: 7938559
[TBL] [Abstract][Full Text] [Related]
15. Transcranial direct current stimulation for the treatment of generalized anxiety disorder: A randomized clinical trial.
de Lima AL; Braga FMA; da Costa RMM; Gomes EP; Brunoni AR; Pegado R
J Affect Disord; 2019 Dec; 259():31-37. PubMed ID: 31437698
[TBL] [Abstract][Full Text] [Related]
16. Agomelatine in generalized anxiety disorder: an active comparator and placebo-controlled study.
Stein DJ; Ahokas A; Márquez MS; Höschl C; Oh KS; Jarema M; Avedisova AS; Albarran C; Olivier V
J Clin Psychiatry; 2014 Apr; 75(4):362-8. PubMed ID: 24569045
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological functioning in young subjects with generalized anxiety disorder with and without pharmacotherapy.
Tempesta D; Mazza M; Serroni N; Moschetta FS; Di Giannantonio M; Ferrara M; De Berardis D
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():236-41. PubMed ID: 23796524
[TBL] [Abstract][Full Text] [Related]
18. Ramelteon for insomnia symptoms in a community sample of adults with generalized anxiety disorder: an open label study.
Gross PK; Nourse R; Wasser TE
J Clin Sleep Med; 2009 Feb; 5(1):28-33. PubMed ID: 19317378
[TBL] [Abstract][Full Text] [Related]
19. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.
Woelk H; Schläfke S
Phytomedicine; 2010 Feb; 17(2):94-9. PubMed ID: 19962288
[TBL] [Abstract][Full Text] [Related]
20. A pilot controlled trial of bupropion XL versus escitalopram in generalized anxiety disorder.
Bystritsky A; Kerwin L; Feusner JD; Vapnik T
Psychopharmacol Bull; 2008; 41(1):46-51. PubMed ID: 18362870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
